Home
According to a new report on the size of the allergy drug market in the US, allergy sufferers could be spending $14.7 billion by 2015. That's in the US alone. Seems that if you are looking for a good investment, you might want to buy stock in companies that sell ...
Allergy shots for hayfever may become a thing of the past: a new treatment called Grazax might just win over those who hate needles. Grazax is a prescription medication that has already been approved in Europe. It's specifically targeted at hayfever and grass pollen allergies. Unlike traditional immunotherapy which requires a ...
Nutritional researchers from California have found that antioxidants really are the fountain of youth. In fact, people who consume more of these valuable nutrients (found in fruits and vegetables) age at almost half the rate of others who don't. Apparently, antioxidants slow down cell division. Now, while replacing "old" cells ...
I've written before on how our family has a lot of history with allergies - which pretty much guaranteed that my kids would also face the challenge of allergies. Little did I know what I was in for. Long story short (which you will be able to read as a serial ...
If you thought that the only way to get allergy shots against grass allergens was in your arm, think again. Alk-Abello, a company out of Denmark, has developed a product called GRAZAX®. Grazax is a once daily allergy "vaccination" tablet: the principle is the same as other immunotherapy approaches, but there ...